Interventions for preventing infection in nephrotic syndrome

Area of Science:

• Nephrology
• Pediatrics
• Infectious Diseases

Background:

• Infection is a major complication in nephrotic syndrome, particularly in children, leading to significant morbidity and mortality.
• Various prophylactic interventions are used to mitigate infection risk, but their evidence base and efficacy remain unclear.

Purpose of the Study:

• To evaluate the benefits and harms of prophylactic interventions for preventing infections in pediatric and adult nephrotic syndrome patients.
• To assess the scientific rigor of existing evidence for infection prevention strategies in nephrotic syndrome.

Main Methods:

• Systematic review of randomized controlled trials (RCTs) and quasi-RCTs.
• Searched multiple databases (Cochrane Renal Group, CENTRAL, MEDLINE, EMBASE, CBMdisc) and other sources up to February 2003.
• Included studies comparing pharmacological or non-pharmacological interventions against baseline treatment for infection prevention.

Main Results:

• Five RCTs involving 308 children (no adult trials) were identified, all from China.
• Intravenous immunoglobulin (IVIG), thymosin, and TIAOJINING showed significant reductions in infection risk (nosocomial or unspecified) compared to baseline treatment alone.
• No serious adverse events were reported; antibiotic prophylaxis and pneumococcal vaccination were not evaluated in the included RCTs.

Conclusions:

• IVIG, thymosin, and TIAOJINING show potential for preventing infections in children with nephrotic syndrome without apparent serious adverse events.
• The overall methodological quality of the included trials was poor, with small sample sizes and limited generalizability due to their origin (China).
• Strong evidence supporting the routine use of these prophylactic interventions is currently lacking.